Radiofrequency endometrial ablation for the treatment of abnormal uterine bleeding literature review
DOI:
https://doi.org/10.56294/saludcyt2024.1291Keywords:
endometrial ablation, radiofrequency, abnormal uterine bleedingAbstract
This systematic review aims to evaluate the effectiveness, safety, and acceptability of radiofrequency endometrial ablation (RFA) for the treatment of abnormal uterine bleeding (AUB). The study focuses on the comparison of RFA with other techniques and includes a search in databases such as PubMed and Scopus, as well as Google Scholar. The inclusion criteria were articles that addressed RFA for AUB, presented or synthesized scientific evidence on its efficacy, safety, or patient satisfaction, and did not limit themselves to technical aspects of the procedure. The results showed that RFA is an effective and safe treatment for AUB, with a rapid recovery and reduced need for additional surgery. However, it is associated with side effects such as pelvic pain, infection, and uterine perforation. The study also highlights the importance of considering patient preferences and clinical variability when choosing the best treatment for AUB
References
1. Chacón Campos N, Pizarro Madrigal M, Guerrero Hines C. Sangrado uterino anormal en etapa reproductiva. Revista Medica Sinergia 2022;7. https://doi.org/10.31434/rms.v7i5.808.
2. Nazaryan H, Watson M, Ellingham D, Thakar S, Wang A, Pai M, et al. Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis - PubMed. Syst Rev 2023;12. https://doi.org/10.1186/s13643-023-02222-4.
3. Pinkerton J. Sangrado uterino anormal - Ginecología y obstetricia. Manual MSD versión para profesionales 2023. https://www.msdmanuals.com/es/professional/ginecolog%C3%ADa-y-obstetricia/anomal%C3%ADas-menstruales/sangrado-uterino-anormal-debido-a-disfunci%C3%B3n-ovulatoria-sua-o (accedido 4 de marzo de 2024).
4. Cañete Palomo ML. Técnicas no quirúrgicas para el tratamiento de los miomas uterinos: embolización de las arterias uterinas (EAU), ultrasonido focalizado de alta intensidad (HIFU) y ablación por radiofrecuencia (ARF). Medicina Clínica 2023;161:S27-31. https://doi.org/10.1016/j.medcli.2023.07.007.
5. Jones S, O’Donovan P, Toub D. Radiofrequency Ablation for Treatment of Symptomatic Uterine Fibroids. Obstetrics and Gynecology International 2012;2012:1-7. https://doi.org/10.1155/2012/194839.
6. Caruso A, Rodríguez Pérez A, Cabezas Palacios MN, Valdés Hernández J, Guadix Martín MP. Perforación intestinal tras ablación por radiofrecuencia de mioma uterino. Reporte de caso y revisión bibliográfica. Clínica e Investigación en Ginecología y Obstetricia 2022;49:100715. https://doi.org/10.1016/j.gine.2021.100715.
7. Fernández Parra J, Alvarez López C, Martínez Morales S. Actualización sobre el sangrado menstrual abundante. Progresos de obstetricia y ginecología: revista oficial de la Sociedad Española de Ginecología y Obstetricia 2020;63:68-80.
8. Aragón Albillosa M, García Pérez M, Fernández Sorianoa MA, Fiol Ruiza G, Pérez Lucasa R. Malformación arteriovenosa uterina como causa de hemorragia puerperal tardía. Progresos de Obstetricia y Ginecología 2010;53. https://doi.org/10.1016/j.pog.2009.09.004.
9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Rev Esp Cardiol 2021;74:790-9. https://doi.org/10.1016/j.recesp.2021.06.016.
10. Beelen P, Van den Brink MJ, Herman MC, Geomini PMAJ, Dekker J, Duijnhoven, et al. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding. Am J Obstet Gynecol 2021;224. https://doi.org/10.1016/j.ajog.2020.08.016.
11. Liao H, Zhang Q. Clinical efficacy of ultrasound-guided radiofrequency ablation and lauromacrogol sclerotherapy for uterine fibroids s. f.
12. Subbaiah M, Selvest N, Maurya D. Comparison of Bipolar Ball Endometrial Ablation and Transcervical Resection of the Endometrium in the Treatment of Heavy Menstrual Bleeding: A Randomized Clinical Trial. Gynecol Minim Invasive Ther 2021;10. https://doi.org/10.4103/gmit.gmit_88_20.
13. Klebanoff JS, Patel NR, Sloan NL. Utility of anesthetic block for endometrial ablation pain: a randomized controlled trial. Am J Obstet Gynecol 2018;218:225.e1-225.e11. https://doi.org/10.1016/j.ajog.2017.11.571.
14. Cooper K, McCormack K, Breeman S, Wood J, Scott NW, Clark J, et al. HEALTH: laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: study protocol for a randomised controlled trial. Trials 2018;19:63. https://doi.org/10.1186/s13063-017-2374-9.
15. Cooper K, Breeman S, Scott NW, Scotland G, Clark J, Hawe J. Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial - The Lancet. The Lancet 2019;394. https://doi.org/10.1016/S0140-6736(19)31790-8.
16. Jonsdottir G, Beermann M, Cronsioe AL, Hasselrot K, Kallner HK. Ultrasound guided microwave ablation compared to uterine artery embolization treatment for uterine fibroids - a randomized controlled trial. Int J Hyperthermia 2022;39:341-7. https://doi.org/10.1080/02656736.2022.2034991.
17. Riley KA, Benton AS, Deimling TA, Kunselman AR, Harkins GJ. Surgical Excision Versus Ablation for Superficial Endometriosis-Associated Pain: A Randomized Controlled Trial. J Minim Invasive Gynecol 2019;26:71-7. https://doi.org/10.1016/j.jmig.2018.03.023.
18. Rattray DD, Weins L, Regush LC, Bowen JM, O’Reilly D, Thiel JA. Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada. Clinicoecon Outcomes Res 2018;10:201-12. https://doi.org/10.2147/CEOR.S155038.
19. Sarmento ACA, Fernandes FS, Costa APF, Medeiros KS, Crispim JC, Gonçalves AK. Microablative fractional radiofrequency for the genitourinary syndrome of menopause: protocol of randomised controlled trial. BMJ Open 2021;11:e046372. https://doi.org/10.1136/bmjopen-2020-046372.
20. Hussein IR, Elomda FA-A, Elboghdady AA. A comparison Between the Effect of Metformin and Progesterone on the Endometrium in cases of peri menopausal bleeding. Al-Azhar International Medical Journal 2022;3:102-7. https://doi.org/10.21608/AIMJ.2022.108415.1691.
21. Wang C, Sun J, Gou L, Song D, Zhang X, Zhuang L. Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases. Frontiers on Oncology 2022;12. https://doi.org/10.3389/fonc.2022.1014465.
22. Bosquet EG, Bosquet JG. González-Merlo. Ginecología. Elsevier Health Sciences; 2020.
23. Lara Velásquez E, Calderaro Di Ruggiero F, Escalona Bonilla S. Cáncer de cuello uterino: importancia de la nueva estadificación FIGO. Gaceta Médica de Caracas 2021;1129:S713. https://doi.org/10.47307/GMC.2021.129.s4.7.
24. Sarango Lapo PJ, Sarmiento Mogrovejo TP. Hemorragia uterina anormal: correlación ecográfica-anatomopatológica en pacientes de 35 a 60 años del Hospital Vicente Corral Moscoso. Cuenca 2018. Universidad de Cuenca. Cuenca, Ecuador. https://dspace.ucuenca.edu.ec/bitstream/123456789/32114/1/TRABAJO%20DE%20TITULACION.pdf.
Published
Issue
Section
License
Copyright (c) 2024 Maria de los Angeles Guanin Choco, Gabriela Socorro Salgado Oviedo (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
